MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling

Author： Wasielewski Marijke   Nagel Jord   Brekelmans Cecile   Klijn Jan   Ouweland Ans   Meijers-Heijboer Hanne   Schutte Mieke  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.104, Iss.2, 2007-08, pp. : 153-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer

By                            

Oncology Reports, Vol. 27, Iss. 3, 2012-01 ,pp. : 673-677

Spandidos Publications

Access to resources Recommend Favorite

Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk

By Fu Qiang   Zhang Guoqiang   Chen Hongwei   Zheng Youwei   Cheng Jing  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3721-3729

Springer Publishing Company

Access to resources Recommend Favorite

MDM2 SNP309 polymorphism is associated with lung cancer risk in women: A meta-analysis using METAGEN

By                

Experimental and Therapeutic Medicine, Vol. 4, Iss. 4, 2012-01 ,pp. : 569-576

Spandidos Publications

Access to resources Recommend Favorite

The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses’ health studies

By Cox David   Deer Dwayne   Guo Qun   Tworoger Shelley   Hankinson Susan   Hunter David   Vivo Immaculata  

Cancer Causes and Control, Vol. 18, Iss. 6, 2007-08 ,pp. : 621-625

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen Receptor Beta (ESR2) Polymorphisms in Familial and Sporadic Breast Cancer

By Maguire Paula  

Breast Cancer Research and Treatment, Vol. 94, Iss. 2, 2005-11 ,pp. : 145-152

Springer Publishing Company

Access to resources Recommend Favorite